Grup de recerca de biomarcadors en càncer (GReBiC)
- Nombre de publicacions
- 495
Publicacions
-
Griguolo, G; Serna, G; Pascual, T; Fasani, R; Chic, N; Pare, L; Pernas, S; Munoz, M; Oliveira, M; Vidal, M; Cussac, AL; Cortes, J; Galvan, P; Bermejo, B; Martinez, N; Lopez, R; Morales, S; Villagrasa, P; Prat, A; Nuciforo, P
Characterization of immune microenvironment before and following anti-HER2 neoadjuvant therapy (NAT)
ANNALS OF ONCOLOGY 31 19-19. .
-
Porcel, JM; Torres, M; Pardina, M; Civit, C; Salud, A; Bielsa, S
Predictors of Indwelling Pleural Catheter Removal and Infection A Single-center Experience With 336 Procedures
JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY 27 86-94. .
-
Porcel, JM; Ferreiro, L; Rumi, L; Espino-Paisan, E; Civit, C; Pardina, M; Schoenenberger-Arnaiz, JA; Valdes, L; Bielsa, S
Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial
Pleura and Peritoneum 5 20190027-20190027. .
-
Wang, E; Sorolla, MA; Krishnan PDG; Sorolla, A
From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds.
Biomolecules 10 -. .
-
Martin, M; Zielinski, C; Ruiz-Borrego, M; Carrasco, E; Ciruelos, E; Munoz, M; Bermejo, B; Margeli, M; Turner, N; Casas, M; Anton, A; Csoszi, T; Corsaro, M; Murillo, L; Morales, S; Alba, E; Bartlett, CH; Koehler, M; Guerrero, A; Kahan, Z; Gil-Gil, M
Results from PEARL study (GEICAM/2013-02_CECOG/BC.1.3.006): A phase 3 trial of Palbociclib (PAL) in combination with endocrine therapy (ET) versus Capecitabine (CAPE) in hormonal receptor (HR)-positive/human epidermal growth factor receptor (HER) 2-negative metastatic breast cancer (MBC) patients (pts) whose disease progressed on aromatase inhibitors (AIs)
CANCER RESEARCH 80 -. .
-
Braso-Maristany, F; Griguolo, G; Pascual, T; Pare, L; Nuciforo, P; Llombart-Cussac, A; Bermejo, B; Oliveira, M; Morales, S; Martinez, N; Vidal, M; Adamo, B; Martinez, O; Pernas, S; Lopez, R; Muñoz M; Chic, N; Galvan, P; Garau, I; Manso, L; Alarcon, J; Martinez, E; Gregorio, S; Gomis, RR; Villagrasa, P; Cortes, J; Ciruelos, E; Prat, A
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade.
Nature Communications 11 385-385. .
-
Tur Martínez J; Escartin, A; Pardina, M; Olsina, JJ
Celiacomesenteric trunk: A rare vascular variant
CIRUGIA ESPANOLA 98 46-46. .
-
Sastre J; Orden V; Martínez A; Bando I; Balbín M; Bellosillo B; Palanca S; Peligros Gomez MI; Mediero B; Llovet P; Moral VM; Viéitez JM; García-Alfonso P; Calle SG; Ortiz-Morales MJ; Salud A; Quintero G; Lopez C; Díaz-Rubio E; Aranda E
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
Clinical Colorectal Cancer 19 110-116. .
-
Quintela-Fandino, M; Morales, S; Cortes-Salgado, A; Manso, L; Apala, JV; Munoz, M; Cudos, AG; Fortuny, JS; Gion, M; Lopez-Alonso, A; Cortes, J; Guerra, J; Malon, D; Caleiras, E; Mulero, F; Mouron, S
Randomized Phase O/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer
CLINICAL CANCER RESEARCH 26 35-45. .
-
Prat, A; Pascual, T; De Angelis, C; Gutierrez, C; Llombart-Cussac, A; Wang, T; Cortes, J; Rexer, B; Pare, L; Forero, A; Wolff, AC; Morales, S; Adamo, B; Braso-Maristany, F; Vidal, M; Veeraraghavan, J; Krop, I; Galvan, P; Pavlick, AC; Bermejo, B; Izquierdo, M; Rodrik-Outmezguine, V; Reis-Filho, JS; Hilsenbeck, SG; Oliveira, M; Dieci, MV; Griguolo, G; Fasani, R; Nuciforo, P; Parker, JS; Conte, P; Schiff, R; Guarneri, V; Osborne, CK; Rimawi, MF
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 112 46-54. .
-
Manso L; Hernando C; Galán M; Oliveira M; Cabrera MA; Bratos R; Rodríguez CA; Ruiz-Borrego M; Blanch S; Llombart-Cussac A; Delgado-Mingorance JI; Álvarez-Busto I; Gallegos I; González-Cortijo L; Morales S; Aguirre E; Hernando BA; Ballesteros A; Alés-Martínez JE; Reboredo C; Oltra A; González-Cao M; Santisteban M; Malón D; Echeverría I; García-Garre E; Vega E; Servitja S; Andrés R; Robles CE; López R; Galve E; Echarri MJ; Legeren M; Moreno F
Palbociclib combined with endocrine therapy in heavily pretreated HR(+)/HER2(-) advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).
BREAST 54 286-292. .
-
Porcel JM
Natriuretic peptides in pleural effusions: Beyond a diagnosis of heart failure.
RESPIROLOGY 25 1021-1022. .
